NEOS high Volatility towards FDA decision. 10Q:"At March 31, 2017, the Company held $43.7 million in cash and cash equivalents and $10.6 million in short-term investments"."We believe that our existing cash and cash equivalents and short-term investments will be sufficient to fund our anticipated operating requirements for at least the next twelve months"
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.